Literature DB >> 20820969

Congenital dyserythropoietic anemia.

Takahiro Kamiya1, Atsushi Manabe.   

Abstract

Congenital dyserythropoietic anemias (CDAs) are a heterogeneous group of rare hereditary disorders of erythropoiesis characterized by morphologic abnormal erythroblasts in the bone marrow. Three types of the disease are known as type I, II and III, and the variant type of CDA and several minor subgroups of CDA have been also reported since the first classification. Recently, responsible genes for type I (CDAN1) and type II (SEC23B) have been identified and the molecular pathogenesis of the disease is currently being explored. Although CDAs rarely transform to myelodysplastic syndrome or leukemia, the disease is important to understand the mechanism of hemopoiesis in humans.

Entities:  

Mesh:

Year:  2010        PMID: 20820969     DOI: 10.1007/s12185-010-0667-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  47 in total

1.  Localization of the congenital dyserythropoietic anemia II locus to chromosome 20q11.2 by genomewide search.

Authors:  P Gasparini; E Miraglia del Giudice; J Delaunay; A Totaro; M Granatiero; S Melchionda; L Zelante; A Iolascon
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

2.  Localization of the gene for congenital dyserythropoietic anemia type I to a <1-cM interval on chromosome 15q15.1-15.3.

Authors:  H Tamary; L Shalmon; H Shalev; A Halil; D Dobrushin; N Ashkenazi; M Zoldan; P Resnitzky; M Korostishevsky; B Bonne-Tamir; R Zaizov
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

3.  Electron and light microscopic study of the erythroblasts of patients with congenital dyserythropoietic anemia.

Authors:  H Heimpel; J Forteza-Vila; W Queisser; E Spiertz
Journal:  Blood       Date:  1971-03       Impact factor: 22.113

4.  Determinants of iron status and bilirubin levels in congenital dyserythropoietic anaemia type I.

Authors:  S N Wickramasinghe; S L Thein; S Srichairatanakool; J B Porter
Journal:  Br J Haematol       Date:  1999-12       Impact factor: 6.998

5.  Hepcidin in iron overload disorders.

Authors:  George Papanikolaou; Michalis Tzilianos; John I Christakis; Dionisios Bogdanos; Konstantina Tsimirika; Julie MacFarlane; Y Paul Goldberg; Nikos Sakellaropoulos; Tomas Ganz; Elizabeta Nemeth
Journal:  Blood       Date:  2005-01-25       Impact factor: 22.113

6.  Interferon alpha is an effective therapy for congenital dyserythropoietic anaemia type I.

Authors:  A Shamseddine; A Taher; H Jaafar; J H Haidar; R Nasr; V Arzoumanian; Z Salem; A Bazarbachi
Journal:  Eur J Haematol       Date:  2000-09       Impact factor: 2.997

7.  Molecular analysis of 42 patients with congenital dyserythropoietic anemia type II: new mutations in the SEC23B gene and a search for a genotype-phenotype relationship.

Authors:  Achille Iolascon; Roberta Russo; Maria Rosaria Esposito; Roberta Asci; Carmelo Piscopo; Silverio Perrotta; Madeleine Fénéant-Thibault; Loïc Garçon; Jean Delaunay
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

Review 8.  Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation.

Authors:  Hermann Heimpel; Volker Anselstetter; Ladislav Chrobak; Jonas Denecke; Beate Einsiedler; Kerstin Gallmeier; Antje Griesshammer; Thorsten Marquardt; Gritta Janka-Schaub; Martina Kron; Elisabeth Kohne
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

9.  Congenital dyserythropoietic anemia type II diagnosed in a 69-year-old patient with iron overload.

Authors:  T C Greiner; C P Burns; F R Dick; K M Henry; I Mahmood
Journal:  Am J Clin Pathol       Date:  1992-11       Impact factor: 2.493

10.  Bone marrow transplantation in a case of severe, type II congenital dyserythropoietic anaemia (CDA II).

Authors:  A Iolascon; V Sabato; D de Mattia; F Locatelli
Journal:  Bone Marrow Transplant       Date:  2001-01       Impact factor: 5.483

View more
  5 in total

1.  Compound heterozygosity for two novel mutations of the SEC23B gene in congenital dyserythropoietic anemia type II.

Authors:  Shanshan Chen; Ziwen Guo; Yongbin Ye; Shanhong Yang; Guinian Huang
Journal:  Int J Hematol       Date:  2021-04-29       Impact factor: 2.490

2.  Congenital dyserythropoietic anemia type 1 with a novel mutation in the CDAN1 gene previously diagnosed as congenital hemolytic anemia.

Authors:  Hisanori Fujino; Sayoko Doisaki; Young-Dong Park; Asahito Hama; Hideki Muramatsu; Seiji Kojima; Shinichi Sumimoto
Journal:  Int J Hematol       Date:  2013-04-19       Impact factor: 2.490

3.  Whole-exome analysis to detect congenital hemolytic anemia mimicking congenital dyserythropoietic anemia.

Authors:  Motoharu Hamada; Sayoko Doisaki; Yusuke Okuno; Hideki Muramatsu; Asahito Hama; Nozomu Kawashima; Atsushi Narita; Nobuhiro Nishio; Kenichi Yoshida; Hitoshi Kanno; Atsushi Manabe; Takashi Taga; Yoshiyuki Takahashi; Satoru Miyano; Seishi Ogawa; Seiji Kojima
Journal:  Int J Hematol       Date:  2018-06-23       Impact factor: 2.490

Review 4.  The pathogenesis, diagnosis and management of congenital dyserythropoietic anaemia type I.

Authors:  Noémi B A Roy; Christian Babbs
Journal:  Br J Haematol       Date:  2019-03-05       Impact factor: 6.998

5.  Diagnosis: Congenital Dyserythropoietic Anemia Type 2 Due to Compound Heterozygote Mutation in SEC23B Gene.

Authors:  Fatih Demircioğlu; Mustafa Erkoçoğlu; Mustafa Dilek; Mervan Bekdaş; Sevil Göksügür; Semra Büyükkorkmaz; Seher Açar
Journal:  Turk J Haematol       Date:  2015-09       Impact factor: 1.831

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.